InvestorsHub Logo
Followers 2
Posts 485
Boards Moderated 0
Alias Born 03/22/2012

Re: Lakersrback post# 14603

Saturday, 01/05/2019 3:33:38 PM

Saturday, January 05, 2019 3:33:38 PM

Post# of 27409
me and the rest of the world prefer the Griefwald study pearsby, 20 patients on their deathbed with refractory sepsis, with a 0-10% chance, at best of living. They were treated with Cytoborb and 41% survived after 28 days! Now that is a miracle treatment pearsby.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CTSO News